These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Catheter Ablation of Ventricular Tachycardia in Structural Heart Disease: Indications, Strategies, and Outcomes-Part II. Dukkipati SR; Koruth JS; Choudry S; Miller MA; Whang W; Reddy VY J Am Coll Cardiol; 2017 Dec; 70(23):2924-2941. PubMed ID: 29216988 [TBL] [Abstract][Full Text] [Related]
44. Results of recent studies in catheter ablation of ventricular tachycardias: in whom to abandon the ICD? Arya A; Piorkowski C; Kircher S; Sommer P; Bollmann A; Gaspar T; Hindricks G Herz; 2009 Nov; 34(7):539-44. PubMed ID: 20091253 [TBL] [Abstract][Full Text] [Related]
45. Mapping and ablation procedures for the treatment of ventricular tachycardia. Killu AM; Mulpuru SK; Asirvatham SJ Expert Rev Cardiovasc Ther; 2016 Sep; 14(9):1071-87. PubMed ID: 27269734 [TBL] [Abstract][Full Text] [Related]
46. Pharmacologic and nonpharmacologic treatment of ventricular arrhythmias in heart failure. Stevenson WG; Sweeney MO Curr Opin Cardiol; 1997 May; 12(3):242-50. PubMed ID: 9243081 [TBL] [Abstract][Full Text] [Related]
47. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone. Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778 [TBL] [Abstract][Full Text] [Related]
48. Catheter ablation for ventricular tachycardia in structural heart disease. Macintyre CJ; Sapp JL Can J Cardiol; 2014 Feb; 30(2):244-6. PubMed ID: 24373758 [TBL] [Abstract][Full Text] [Related]
49. Patients treated with catheter ablation for ventricular tachycardia after an ICD shock have lower long-term rates of death and heart failure hospitalization than do patients treated with medical management only. Bunch TJ; Weiss JP; Crandall BG; Day JD; May HT; Bair TL; Osborn JS; Mallender C; Fischer A; Brunner KJ; Mahapatra S Heart Rhythm; 2014 Apr; 11(4):533-40. PubMed ID: 24333283 [TBL] [Abstract][Full Text] [Related]
50. Ten-year outcomes of monomorphic ventricular tachycardia catheter ablation in repaired tetralogy of Fallot. Laredo M; Frank R; Waintraub X; Gandjbakhch E; Iserin L; Hascoët S; Himbert C; Gallais Y; Hidden-Lucet F; Duthoit G Arch Cardiovasc Dis; 2017 May; 110(5):292-302. PubMed ID: 28347634 [TBL] [Abstract][Full Text] [Related]
52. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A; JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391 [TBL] [Abstract][Full Text] [Related]
53. Catheter Ablation of Ventricular Tachycardia in Structurally Normal Hearts: Indications, Strategies, and Outcomes-Part I. Dukkipati SR; Choudry S; Koruth JS; Miller MA; Whang W; Reddy VY J Am Coll Cardiol; 2017 Dec; 70(23):2909-2923. PubMed ID: 29216987 [TBL] [Abstract][Full Text] [Related]
54. [Radiofrequency ablation in ventricular tachycardia: an alternative to implanted cardioverter defibrillator?]. Noble S; Shah D Rev Med Suisse; 2006 May; 2(67):1406, 1408-11. PubMed ID: 16786957 [TBL] [Abstract][Full Text] [Related]
55. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]